Comparison of the Detection Rates of 50 Gr-100 Gr OGTT and 75 Gr OGTT That Require Medical Treatment of GDM

Launched by ANKARA CITY HOSPITAL BILKENT · Oct 9, 2020

Keywords

ClinConnect Summary

This clinical trial is studying two different tests used to detect gestational diabetes, a condition that can affect pregnant women. The two tests being compared are the 50-gram and 75-gram oral glucose tolerance tests (OGTT). The goal of the study is to see which test is better at identifying women who need medical treatment for gestational diabetes.

To participate in this trial, you must be a pregnant woman. However, if you have already been diagnosed with diabetes or if you are carrying more than one baby, you won't be eligible to join. If you decide to take part, you can expect to undergo one of the glucose tests, and your health will be closely monitored throughout the study. This research is important because it could help doctors choose the best ways to identify and treat gestational diabetes, ensuring better health for both mothers and their babies.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women
• Exclusion Criteria:
• • Already diagnosed by diabetes mellitus
• • Multiple pregnancy